Stabilitech is awarded Technology Strategy Board grant

Stabilitech Ltd (London) announced today that it has been awarded a grant by the Technology Strategy Board as part of its competition on Detection and Indentification of Infectious Agents: Fighting Infection through Detection.

Stabilitech will apply its broadly applicable stabilisation technology to stabilise a range of antibodies and antibody conjugates against infectious disease, in order to enable storage and use of diagnostics at ambient and elevated temperatures. The grant is for a feasibility study of one year, towards which the Technology Strategy Board will provide up to £120,000.